China National Medicines Corp Ltd (600511) — Cash Flow-to-Debt Ratio
China National Medicines Corp Ltd (600511) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-540.00 Million could theoretically repay 0% of its total liabilities (CN¥15.19 Billion) in one year. Explore how much of China National Medicines Corp Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China National Medicines Corp Ltd Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for China National Medicines Corp Ltd across 24 annual periods. Also explore China National Medicines Corp Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for China National Medicines Corp Ltd (2001–2024)
Year-by-year debt coverage analysis for China National Medicines Corp Ltd. For market capitalisation and broader financial context, see China National Medicines Corp Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥1.66 Billion | CN¥15.95 Billion | ▼ -43.1% |
| 2023 | 0.18x | CN¥2.73 Billion | CN¥14.92 Billion | ▲ +4.9% |
| 2022 | 0.17x | CN¥2.40 Billion | CN¥13.75 Billion | ▲ +16.8% |
| 2021 | 0.15x | CN¥1.96 Billion | CN¥13.12 Billion | ▲ +35.4% |
| 2020 | 0.11x | CN¥1.30 Billion | CN¥11.81 Billion | ▼ -25.3% |
| 2019 | 0.15x | CN¥1.78 Billion | CN¥12.03 Billion | ▲ +63.9% |
| 2018 | 0.09x | CN¥981.65 Million | CN¥10.90 Billion | ▼ -10.2% |
| 2017 | 0.10x | CN¥1.07 Billion | CN¥10.71 Billion | ▼ -42.6% |
| 2016 | 0.17x | CN¥591.25 Million | CN¥3.38 Billion | ▲ +20.7% |
| 2015 | 0.14x | CN¥440.29 Million | CN¥3.04 Billion | ▲ +95.5% |
| 2014 | 0.07x | CN¥218.94 Million | CN¥2.96 Billion | ▲ +15.1% |
| 2013 | 0.06x | CN¥185.56 Million | CN¥2.88 Billion | ▼ -6.9% |
| 2012 | 0.07x | CN¥185.87 Million | CN¥2.69 Billion | ▲ +137.6% |
| 2011 | -0.18x | CN¥-370.56 Million | CN¥2.02 Billion | ▼ -218.2% |
| 2010 | 0.16x | CN¥318.21 Million | CN¥2.05 Billion | ▲ +3.0% |
| 2009 | 0.15x | CN¥255.18 Million | CN¥1.69 Billion | ▼ -21.7% |
| 2008 | 0.19x | CN¥217.10 Million | CN¥1.13 Billion | ▲ +197.7% |
| 2007 | 0.06x | CN¥79.48 Million | CN¥1.23 Billion | ▼ -59.0% |
| 2006 | 0.16x | CN¥121.50 Million | CN¥771.05 Million | ▲ +29.8% |
| 2005 | 0.12x | CN¥92.20 Million | CN¥759.27 Million | ▲ +74.0% |
| 2004 | 0.07x | CN¥49.18 Million | CN¥704.48 Million | ▲ +8123.0% |
| 2003 | 0.00x | CN¥526.15K | CN¥619.80 Million | ▼ -97.7% |
| 2002 | 0.04x | CN¥15.19 Million | CN¥408.75 Million | ▲ +194.8% |
| 2001 | -0.04x | CN¥-11.80 Million | CN¥300.99 Million | — |